锝-99m 市场基于(关键区域、市场参与者、规模和份额)- 预测至 2030 年

  • Report Code : TIPRE00029981
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Technetium-99m Market Trends, Growth, Size, Share by 2030

Buy Now

【研究报告】99m锝市场规模预计将从2022年的42.6815亿美元增长到2030年的60.7286亿美元;预计 2022 年至 2030 年复合年增长率为 4.5%。
Technetium-99m 市场洞察和分析师观点:
Technetium-99m 是锝同位素 Technetium-99 的亚稳态核异构体。 Technetium-99m 是全球医疗诊断过程中最常用的医用放射性同位素之一。推动市场的关键因素是慢性病的高患病率和核成像技术的进步。然而,放射性药物的保质期短阻碍了99m锝市场的发展。
增长动力和限制:
心血管疾病(CVD)、呼吸系统疾病和癌症等慢性病的高患病率将推动锝-99m市场的发展。对单光子发射计算机断层扫描 (SPECT) 诊断程序的需求,推动了 99m 锝市场的增长。据华盛顿州卫生部称,99m 锝用于与骨骼和心肌相关的诊断程序。它还用于与肺、肝、脾、骨髓、肾、脑、甲状腺、胆囊、唾液腺、心脏血池、感染等相关的医学研究。因此,慢性病的高患病率将增加锝-99m 诊断的采用。
根据美国心脏病学会基金会的数据,CVD 相关死亡人数从 1990 年的 1,240 万人增加到 2022 年的 1,980 万人。 . 缺血性心脏病仍然是全球心血管疾病死亡的主要原因。同样,根据国际癌症研究机构 (IARC) 的数据,全球癌症病例的患病率很高。据估计,2020 年全球有 1,930 万癌症病例,预计到 2040 年,癌症病例数将达到约 3,020 万。此外,世界卫生组织 (WHO) 指出,全球有超过 17.1 亿人患有癌症肌肉骨骼状况。有效的医学检查是治疗慢性疾病的必要条件,一些医学成像程序还包括用于诊断和检查目的的核物质。 SPECT 中使用锝 99m 和碘 123 等放射性药物,同样,正电子发射断层扫描 (PET) 中使用氟 18 和铜 64。因此,随着慢性病患病率的激增,对医学成像的需求也在增加99m锝市场规模。
然而,放射性药物的保质期短阻碍了市场的增长。放射性药物的保质期主要取决于放射性同位素的半衰期、放射化学稳定性以及制剂中放射性核素杂质的浓度。大多数放射性药物制剂含有半衰期很短的放射性同位素。例如,锝基制剂和 SPECT 制剂必须在制备后 6 小时内使用。无菌撤回第一剂后多剂量放射性药物制剂的保质期取决于微生物学方面的考虑。如果放射性核素的半衰期较短,诊断放射性药物通常在医院放射性药剂科在给患者给药之前制备。例如,锝-99m的物理半衰期为6小时,不会在体内停留太久。因此,短寿命放射性药物正在成为长期手术中的一个令人担忧的问题,这是限制锝-99m市场增长的主要因素。

报告细分和范围:
锝-99m市场增长99m 市场分析是通过考虑以下部分进行的:应用领域和最终用户。根据应用领域,市场分为心血管、骨扫描、呼吸、肿瘤成像等。就最终用户而言,市场分为医院、诊断和成像中心等。 99m锝市场报告的范围涵盖北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本) 、印度、韩国以及亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
细分分析:
根据应用领域,99m 锝市场分为心血管、骨扫描、呼吸、肿瘤成像等。心血管领域在 2022 年占据最大的 Technetium-99m 市场份额。骨扫描领域预计在 2022 年至 2030 年期间复合年增长率最高。
按应用领域划分的 Technetium-99m 市场 – 2022 年和 2030 年
基于最终用户,市场分为医院、诊断和成像中心等。 2022 年,诊断和成像中心领域占据最大的 99m 锝市场份额,预计医院领域在 2022 年至 2030 年期间复合年增长率最高。
区域分析:
从地理上看,全球 99m 锝市场份额市场分为五个关键区域:北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。
2022 年,北美在全球市场中占据最大份额。先进的医疗基础设施的可用性、主要市场参与者的存在、目标病症的发病率和患病率的上升以及该地区主要参与者推出的产品创新可能会在未来几年引入新的 99m 锝市场趋势。据国际癌症研究机构(IARC)预测,美国癌症病例数预计将从2020年的228万例增加到2040年的312万例。因此,包括癌症在内的慢性病的增加将导致美国癌症患者数量增加。刺激了医学成像的需求,从而推动了市场的增长。此外,美国医疗保险和医疗补助服务中心 (CMS) 根据临床实验室改进修正案 (CLIA) 采用了与人体实验室研究相关的标准,这有利地提高了锝-99m 的市场表现。
行业发展和未来机遇:
下面列出了全球市场主要参与者采取的一些举措:
2023 年 11 月,国际原子能机构 (IAEA) 宣布了一项新的协调研究项目 (CRP),旨在创建一个由生产商和研究人员组成的全球网络,以开发新一代 Technetium-99m 试剂盒和放射性药物。 CRP 预计将为创新的 Technetium-99m 放射性药物的制造、质量控制和临床前测试制定标准流程和指南。 CRP 还将专注于需求中与治疗最相关的供应以及创新放射性标记策略的实施。 2023 年 2 月,BWXT Medical 与 Laurentis 完成了关键的 Tc-99m 发生器计划里程碑。 Laurentis Energy Partners 和 BWXT Medical Ltd. 在安大略发电公司 (OPG) 达灵顿核电站安装并调试了一套创新同位素系统,使他们能够生成钼 99 (Mo-99) 同位素。 Mo-99 用于生成 Technetium-99 亚稳态 (Tc-99m),这是核医学中最常用的诊断成像剂之一,有助于检测癌症和心脏病等疾病。达灵顿将成为第一个生产 Mo-99 的商业动力反应堆。 2022 年 2 月,Theragnostics 宣布该公司的放射诊断成像药物 NephroScan(Technetium Tc 99m Succimer 注射套件)获得美国 FDA 批准。 NephroScan 是一种用于制备锝 Tc 99m 琥珀注射液的专有试剂盒,可辅助诊断足月新生儿和成年患者的肾实质疾病。 2021 年 3 月,NorthStar Medical Radioisotopes LLC 和 Ion Beam Applications SA (IBA) 宣布开展合作,以提高锝-99m (Tc-99m)(最广泛使用的医用放射性同位素)的全球可用性。该协议允许美国以外的企业使用 NorthStar 的专利非铀基 Mo-99,该 Mo-99 是通过 IBA 的加速器和光束线生成的。此外,此次合作建立在现有协议的基础上,根据该协议,IBA 将向 NorthStar 提供多达八台 Rhodotron TT 300-HE 电子束加速器。这有助于非铀基 Mo-99 的生产,使 NorthStar 经 FDA 批准且可商业使用的 RadioGenix 系统(锝 Tc 99m 发生器)能够在美国生产 Tc-99m。竞争格局和主要公司:
Lantheus Medical Imaging Inc、Curium、Jubilant Pharma Company、NorthStar Medical Radioisotopes LLC、Sun Pharmaceutical Industries Inc、Advancing Nuclear Medicine、NTP Radioisotopes SOC Ltd、Northwest Medical Isotopes LLC、SHINE Technologies LLC 和 Cardinal Health 是锝中介绍的知名参与者-99m 市场报告。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求并增加其专业产品组合的产品范围。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What factors drive the technetium-99m market?

Key factors driving the market are the high prevalence of chronic diseases and advancements in nuclear imaging techniques.

What is technetium-99m?

Technetium-99m is a metastable nuclear isomer of technetium-99, an isotope of technetium. Technetium-99m is among the most commonly used medical radioisotopes in medical diagnostic procedures globally.

Who are the major players in the technetium-99m market?

The technetium-99m market majorly consists of the players, including Lantheus Medical Imaging Inc, Curium, Jubilant Pharma Company, NorthStar Medical Radioisotopes LLC, Sun Pharmaceutical Industries Inc, Advancing Nuclear Medicine, NTP Radioisotopes SOC Ltd, Northwest Medical Isotopes LLC, SHINE Technologies LLC, and Cardinal Health.

What was the estimated technetium-99m market size in 2022?

The technetium-99m market was valued at US$ 4,268.15 million in 2022.

Which end user segment dominates the technetium-99m market?

Based on end user, the market is segmented into hospitals, diagnostic and imaging centers, and others. In 2022, the diagnostic and imaging centers segment held the largest technetium-99m market share, and the hospitals segment is anticipated to register the highest CAGR during 2022–2030.

What are the growth estimates for the technetium-99m market till 2030?

The technetium-99m market is expected to be valued at US$ 6,072.86 million in 2030.

Which application area segment dominates the technetium-99m market?

Based on application area, the technetium-99m market is segmented into cardiovascular, bone scan, respiratory, tumor imaging, and others. The cardiovascular segment held the largest technetium-99m market share in 2022. The bone scan segment is anticipated to register the highest CAGR during 2022–2030.

The List of Companies - Technetium-99m Market

  1. Lantheus Medical Imaging Inc
  2. Curium
  3. Jubilant Pharma Company
  4. NorthStar Medical Radioisotopes LLC
  5. Sun Pharmaceutical Industries Inc
  6. Advancing Nuclear Medicine
  7. NTP Radioisotopes SOC Ltd
  8. Northwest Medical Isotopes LLC
  9. SHINE Technologies LLC
  10. Cardinal Health

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports